Glucosyltransferase activity of Clostridium difficile Toxin B is essential for disease pathogenesis

Gut Microbes

Volumn 6, Issue 4, 2015, Pages 221-224

  Yang, Zhiyong ^a   Zhang, Yongrong ^a   Huang, Tuxiong ^a   Feng, Hanping ^a  

^a UNIVERSITY OF MARYLAND DENTAL SCHOOL   (United States)

Author keywords

Clostridium difficile; Glucosyltransferase; Pathogenesis; Toxin

Indexed keywords

BACTERIUM LYSATE; CLOSTRIDIUM DIFFICILE TOXIN B; GLUCOSYLTRANSFERASE; GREEN FLUORESCENT PROTEIN; BACTERIAL PROTEIN; BACTERIAL TOXIN; TOXB PROTEIN, CLOSTRIDIUM DIFFICILE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACILLUS MEGATERIUM; CONTROLLED STUDY; ENTERITIS; ENZYME ACTIVITY; EXPERIMENTAL DISEASE; FEEDING; MOUSE; NONHUMAN; PEPTOCLOSTRIDIUM DIFFICILE; TOXEMIA; WEIGHT REDUCTION; ANIMAL; BODY WEIGHT; CECUM; CLOSTRIDIUM INFECTION; CYTOCHEMISTRY; DISEASE MODEL; GENETICS; INTESTINE; METABOLISM; MICROSCOPY; PATHOLOGY; SURVIVAL ANALYSIS;

ANIMALS; BACILLUS MEGATERIUM; BACTERIAL PROTEINS; BACTERIAL TOXINS; BODY WEIGHT; CECUM; CLOSTRIDIUM INFECTIONS; DISEASE MODELS, ANIMAL; GLUCOSYLTRANSFERASES; HISTOCYTOCHEMISTRY; INTESTINES; MICE; MICROSCOPY; SURVIVAL ANALYSIS;

EID: 84944448131     PISSN: 19490976     EISSN: 19490984     Source Type: Journal    
DOI: 10.1080/19490976.2015.1062965     Document Type: Article

References (11)

1. Voth DE, Ballard JD. Clostridium difficile toxins: mechanism of action and role in disease. Clin Microbiol Rev 2005; 18:247-63; PMID:15831824; http:// dx.doi.org/10.1128/CMR.18.2.247-263.2005.
2. Just I, Selzer J, Wilm M, von Eichel-Streiber C, Mann M, Aktories K. Glucosylation of Rho proteins by Clostridium difficile toxin B. Nature 1995; 375:500-3; PMID:7777059; http://dx.doi.org/10.1038/375500a0.
3. Just I, Wilm M, Selzer J, Rex G, von Eichel-Streiber C, Mann M, Aktories K. The enterotoxin from Clostridium difficile (ToxA) monoglucosylates the Rho proteins. J Biol Chem 1995; 270:13932-6; PMID:7775453; http://dx.doi.org/10.1074/ jbc.270.23.13932.
4. Yang G, Zhou B, Wang J, He X, Sun X, Nie W, Tzipori S, Feng H. Expression of recombinant Clostridium difficile toxin A and B in Bacillus megaterium. BMC Microbiol 2008; 8:192; PMID:18990232; http://dx.doi.org/10.1186/1471-2180-8-192.
5. King AM, Mackin KE, Lyras D. Emergence of toxin Anegative, toxin B-positive Clostridium difficile strains: epidemiological and clinical considerations. Future Microbiol 2015; 10:1-4; PMID:25598331; http://dx. doi.org/10.2217/fmb.14.115.
6. Chaves-Olarte E, Weidmann M, Eichel-Streiber C, Thelestam M. Toxins A and B from Clostridium difficile differ with respect to enzymatic potencies, cellular substrate specificities, and surface binding to cultured cells. J Clin Invest 1997; 100:1734-41; PMID:9312171; http://dx.doi.org/10.1172/ JCI119698.
7. Chumbler NM, Farrow MA, Lapierre LA, Franklin JL, Haslam DB, Goldenring JR, Lacy DB. Clostridium difficile Toxin B causes epithelial cell necrosis through an autoprocessing-independent mechanism. PLoS Pathog 2012; 8:e1003072; PMID:23236283; http:// dx.doi.org/10.1371/journal.ppat.1003072.
8. Wohlan K, Goy S, Olling A, Srivaratharajan S, Tatge H, Genth H, Gerhard R. Pyknotic cell death induced by Clostridium difficile TcdB: Chromatin condensation and nuclear blister are induced independently of the glucosyltransferase activity. Cell Microbiol 2014; 16(11):1678-92; PMID:24898616.
9. D'Auria KM, Kolling GL, Donato GM, Warren CA, Gray MC, Hewlett EL, Papin JA. In vivo physiological and transcriptional profiling reveals host responses to Clostridium difficile toxin A and toxin B. Infect Immun 2013; 81:3814-24; PMID:23897615; http:// dx.doi.org/10.1128/IAI.00869-13.
10. Wang H, Sun X, Zhang Y, Li S, Chen K, Shi L, Nie W, Kumar R, Tzipori S, Wang J, et al. A chimeric toxin vaccine protects against primary and recurrent Clostridium difficile infection. Infect Immun 2012; 80:2678-88; PMID:22615245; http://dx.doi.org/10.1128/ IAI.00215-12.
11. Li S, Shi L, Yang Z, Zhang Y, Perez-Cordon G, Huang T, Ramsey J, Oezguen N, Savidge TC, Feng H. Critical Roles of Clostridium difficile Toxin B Enzymatic Activities in Pathogenesis. Infect Immun 2015; 83:502-13; PMID:25404023; http://dx.doi.org/10.1128/ IAI.02316-14